The RGLS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RGLS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The RGLS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View RGLS Detailed Price Forecast - CNN Money||View RGLS Detailed Summary - Google Finance|
|View RGLS Detailed Summary - Yahoo! Finance||View RGLS Stock Research & Analysis - Zacks.com|
|View RGLS Trends & Analysis - Trade-Ideas||View RGLS Major Holders - Barrons|
|View RGLS Call Transcripts - NASDAQ||View RGLS Breaking News & Analysis - Seeking Alpha|
|View RGLS Annual Report - CompanySpotlight.com||View RGLS OTC Short Report - OTCShortReport.com|
|View RGLS Fundamentals - TradeKing||View RGLS SEC Filings - Bar Chart|
|View Historical Prices for RGLS - The WSJ||View Performance/Total Return for RGLS - Morningstar|
|View the Analyst Estimates for RGLS - MarketWatch||View the Earnings History for RGLS - CNBC|
|View the RGLS Earnings - StockMarketWatch||View RGLS Buy or Sell Recommendations - MacroAxis|
|View the RGLS Bullish Patterns - American Bulls||View RGLS Short Pain Metrics - ShortPainBot.com|
|View RGLS Stock Mentions - StockTwits||View RGLS Stock Mentions - PennyStockTweets|
|View RGLS Stock Mentions - Twitter||View RGLS Investment Forum News - Investor Hub|
|View RGLS Stock Mentions - Yahoo! Message Board||View RGLS Stock Mentions - Seeking Alpha|
|View Insider Transactions for RGLS - SECform4.com||View Insider Transactions for RGLS - Insider Cow|
|View RGLS Major Holdings Summary - CNBC||View Insider Disclosure for RGLS - OTC Markets|
|View Insider Transactions for RGLS - Yahoo! Finance||View Institutional Holdings for RGLS - NASDAQ|
|View RGLS Stock Insight & Charts - FinViz.com||View RGLS Investment Charts - StockCharts.com|
|View RGLS Stock Overview & Charts - BarChart||View RGLS User Generated Charts - Trading View|
Kathryn J. Collier Joins Regulus Board of Directors
Posted on Tuesday April 17, 2018
LA JOLLA, Calif., April 17, 2018 /PRNewswire/ -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced Kathryn J. Collier has joined the Company's board of directors. "I am honored to join the Regulus board and look forward to bringing my strategic, financial, and operational experience and expertise to serve Regulus' board and management," said Kate Collier.
Regulus to Present at the Needham Healthcare Conference
Posted on Tuesday March 20, 2018
Regulus Therapeutics Inc. (RGLS) is a clinical stage biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a rich intellectual property estate to retain its leadership in the microRNA field. Regulus is advancing several programs in renal, hepatic and central nervous systems diseases. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements.
Edited Transcript of RGLS earnings conference call or presentation 7-Mar-18 10:00pm GMT
Posted on Thursday March 08, 2018
Q4 2017 Regulus Therapeutics Inc Earnings Call
Regulus reports 4Q loss
Posted on Wednesday March 07, 2018
The San Diego-based company said it had a loss of 14 cents per share. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for ...